Diagnosis Section Bibliography

• Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991; 41:617-618.
• Barohn RJ, Kissel JT, Warmolts JR, Mendell JR. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol. 1989;46(8):878-884.
• Bouchard C, Lacroix C, Plante V, Adams D, Chedru F, Guglielmi JM, Said G. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 1999;52:498-503.
• Bromberg MB. Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy. Muscle Nerve 1991 Oct;14(10):968-976.
• Busby M, Donaghy M. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients. J Neurol. 2003 Jun;250(6):714-724.
• Chin RL, Latov N, Sander WH, et al. Sensory CIDP presenting as cryptogenic sensory polyneuropathy. Neurology 2003; 60:A314.
• Cleland JC, Malik K, Thaisetthawatkul P, et al. Acute inflammatory demyelinating polyneuropathy: Contribution of a dispersed distal compound muscle action potential to electrodiagnosis. Muscle Nerve online publication in advance of print 7 Mar 2006.
• DeSousa EA, Brannagan TH 3rd. Diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy. Curr Treat Options Neurol. 2006;8(2):91-103.
• Duggins AJ, McLeod JG, Pollard, JD et al. Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain 1999;122:1383-1390.
• Dyck PJ, Lais AC. Ohta M, et al. Chronic inflammatory demyelinating polyradiculoneuropathy. Mayo Clin Proc. 1975; 50:662.
• Dyck PJ, O'Brien P, Oviatt KF, et al. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol. 1982;11:136-141.
• Dyck PJ. Lais AC, Phta M, et al. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc. 1975;50:621-651.
• Haq RU, Fries TJ, Pendlebury WW, Kenny MJ, Badger GJ, Tandan R. Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria. Arch Neurol. 2000 Dec;57(12):1745-1750.
• Hughes R, Bensa S, Willison, H et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol. 2001;50:195-201.
• Hughes RA, Bouche P, Cornblath DR, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on the management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol. 2006;13(4):326-332.
• Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst. 2005;10:220-228.
• Kiefer R, Keissier BC, Brück W, et al. Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies. Brain 1998;121:469-1479.
• Koski CL. Initial and Long-term management of autoimmune neuropathies CNS Drugs 2005;19(12):1-12.
• Latov N. Diagnosis of CIDP. Neurology 2002;59(12Suppl6): S2-S6.
• Leger JM. A review of the medical management of chronic inflammatory demyelinating polyradiculoneuropathy. Expert Opin Pharmacother. 2005;6(4):569-582.
• Magda P, Latov N, Brannagan TH 3rd, Weimer LH, Chin RL, Sander HW. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy.Arch Neurol. 2003 Dec;60:1755-1759.
• Merkies IS, Schmitz PI van der Meche FG, et al. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry.2002;72(5):596-601.
• Merkies IS, Schmitz PI, Samijn JP, et al. Assessing grip strength in healthy individuals and patients with immune-mediated polyneuropathies. Muscle Nerve 2000;23(9):1393-401.
• Merkies IS, Schmitz PI. Getting closer to patients: the INCAT overall disability sumscore relates better to patients' own clinical judgment in immune-mediated polyneuropathies. J Neurol Neurosurg Psychiatry. 2006 Mar 20. E pub ahead of print. Pubmed.gov. PMID 16549419.
• Molenaar DS, Vermeulen M, de Haan RJ. Comparison of electrodiagnostic criteria for demyelination in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). J Neurol. 2002 Apr;249(4):400-403.
• Nicolas G, Maisonobe T, Forestier N, et al. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2002;25:26-30.
• Olney RK, Lewis RA, Putnam TD, Campellone, Jr. JV. Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 2003;27:117-121.
• Pollard JD. Chronic inflammatory demyelinating polyradiculoneuropathy. Curr Opin Neurol. 2002;15(3):279-283.
• Prineas JW. Pathology of inflammatory demyelinating neuropathies. Baillieres Clin Neurol.1994;3:1-24.
• Rajabally YA, Jacob S, Hbahbih M. Optimizing the use of electrophysiology in the diagnosis of chronic inflammatory demyelinating polyneuropathy: a study of 20 cases. J Periph Nerv Sys. 2005;10:282-292.
• Rezania K, Gundogdu B, Soliven B. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. Front Biosci. 2004;9:939-945.
• Rotta FT, Sussman AT, Bradley WG, Ram Ayyar D, Sharma KR, Shebert RT. The spectrum of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci. 2000 Feb 15;173:129-139.
• Sander HW, Latov N. Research criteria for defining patients with CIDP. Neurology 2003 Apr 1;60(8Suppl3):S8-S15.
• Saperstein DS Katz JS, Amato AA, Barohn RJ. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001;24(3):311-324.
• Sinnreich N, Klein CJ, Daube JR, Engelstad J, Spinner RJ, Dyck PJ: Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia. Neurology. 2004 Nov 9;63(9):1662-9.
• Tankisi H, Pugdahl K, Fuglsang-Frederiksen A, Johnsen B, de Carvalho M, Fawcett, PR, Labarre-Vila A, Liguori R, Nix WA, Schofield IS; Esteem Project. Pathophysiology inferred from electrodiagnostic nerve tests and classification of polyneuropathies. Suggested guidelines. Clin Neurophysiol. 2005 Jul;116(7):1571-1580.
• Thaisetthawatkul P, Logigian EL, Herrman DN. Dispersion of distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelianting polyneuropathy. Neurology 2002;59:1526-1532.
• Uncini A, Di Muzio A, Sabatelli M, Magi S, Tonali P, Gambi D. Sensitivity and specificity of diagnostic criteria for conduction block in chronic inflammatory demyelinating polyneuropathy. Electroencephalogr Clin Neurophysiol. 1993 Jun;89(3):161-169.
• Van Asseldonk JT, Van den Berg LH, Kalmijn S, Wokke JH, Franssen H. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy. Brain 2005 Apr;128(Pt 4):880-891.
• van den Bergh PYK, Piéret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2004;29:565-574.
• Wilson J, Chawla J, Fisher M. Sensitivity and specificity of electrodiagnostic criteria for CIDP using ROC curves: comparison to patients with diabetic and MGUS associated neuropathies. J Neurol Sci. 2005 Apr 15;231(1-2):19-28.